AGE PECULIARITIES OF HERPES ZOSTER CLINIC


Cite item

Full Text

Abstract

Herpes zoster is a viral disease that occurs as a result of reactivation of Varicella zoster virus and is characterized by damage to the skin, nervous tissue. This disease develops as a secondary endogenous infection in individuals who have previously had chickenpox. Potential risk factors for herpes zoster are old age, the presence in patients of cancer and / or hematological diseases, diabetes, HIV infection, drug immunosuppression. Changes in socio-economic conditions are accompanied by pathomorphosis of diseases. This fully applies to the infection caused by Varicella zoster virus. Diagnosis of herpes zoster in the prodromal period is difficult, since there are no characteristic bubble rashes. Late diagnosis leads to delayed medical care. The clinical differences of herpes zoster in 78 patients of different age categories were studied: up to 60 years, and after 60 years. The terms of diagnosis, duration of prehospital and hospital stages, clinical symptoms, presence of concomitant pathology and complications were studied. It was shown that the diagnosis of herpes zoster at the prehospital stage was established only in half of the patients, which led to late hospitalization and may have contributed to the development of complications. Among the features of the clinical course, a lower incidence of concomitant pathology and adequate immunoreactivity were noted in persons under the age of 60 years, compared with patients over the age of 60 years. It is assumed that the reactivation of Varicella zoster virus, which is associated in the elderly with immunosuppression against the background of combined chronic somatic pathology, in young people may be due to other reasons, among which may be, including the features of the pathogen.

About the authors

D. M Polyakova

Russian national research medical university named N.I. Pirigov the Ministry of health of Russia

Email: polyakovadacha@mail.ru
клинический ординатор каф. инфекционных болезней и эпидемиологии, ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России 1, Ostrovitaynova st., 117513, Moscow, Russia

V. V Nikiforov

Russian national research medical university named N.I. Pirigov the Ministry of health of Russia

Email: v.v.nikiforov@gmail.com
доктор мед. наук, проф., зав. каф. инфекционных болезней и эпидемиологии, ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России 1, Ostrovitaynova st., 117513, Moscow, Russia

Murad Z. Shakhmardanov

Russian national research medical university named N.I. Pirigov the Ministry of health of Russia

Email: mur2025@rambler.ru
доктор мед. наук, проф., каф. инфекционных болезней и эпидемиологии ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России 1, Ostrovitaynova st., 117513, Moscow, Russia

References

  1. Авдеева М.Г., Аликеева Г.К., Антонова М.В. и др. Инфекционные болезни. Национальное руководство. Под ред. Н.Д. Ющука, Ю.Я. Венгерова. М.; ГОЭТАР; 2018.
  2. Никифоров В.В., Дворников А.С., Шахмарданов М.З., Скрипкина П.А. Реактивация вируса Varicella zoster при ВИЧ-инфекции. Актуальные вопросы. Эпидемиология и инфекционные болезни. 2016; 21(6): 300-3.
  3. Гузовская Т.С., Чистенко Г.Н., Панкратов В.Г., Гумбар С.А. Эпидемиологическая и клиническая характеристика опоясывающего лишая. Проблемы здоровья и экологии. 2008; 3(17): 133-7.
  4. Полякова Д.М., Никифоров В.В., Шахмарданов М.З. Иммунитет и вакцинопрофилактика у взрослых при инфекции, вызываемой вирусом Varicella zoster. Эпидемиология и инфекционные болезни. 2019; 24(2): 84-7.
  5. Маркелова Е.В., Кныш С.В., Невежкина Т.А., Байбарина Е.В. Альфа-герпесвирусы: современный взгляд на структуру. Тихоокеанский медицинский журнал. 2018; 4(74): 5-9.
  6. Онищенко Н.В., Рябоконь Е.В., Фирюлина О.М. Клинические особенности течения опоясывающего герпеса на современном этапе. Клиническая инфектология и паразитология. 2017; (3): 289-93.
  7. Шахмарданов М.З. Инвазивные свойства возбудителя в патогенезе шигеллеза Флекснера 2а. Эпидемиология и инфекционные болезни. 2000; (1): 25.

Copyright (c) 2019 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies